Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The BaleDoneen Method is a healthcare organization that provides a proprietary clinical protocol for the prevention of heart attacks, strokes, and type 2 diabetes. Founded by Dr. Bradley Bale and Dr. Amy Doneen, the company focuses on identifying and treating arterial inflammation rather than relying solely on standard cholesterol management. Their approach utilizes advanced diagnostic tools, including genetic testing and inflammatory biomarker panels, to create personalized risk assessments and treatment plans. The company primarily operates through medical education, offering certification and training for healthcare providers to implement the method in clinical practice. Their evidence-based methodology is widely recognized for its emphasis on the oral-systemic connection and the use of 'optimal' rather than 'normal' laboratory values.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BaleDoneen Method.